Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter - Interim Management Statement

30 Apr 2013 12:24

RNS Number : 6138D
British Smaller Companies VCT2 Plc
30 April 2013
 



 

British Smaller Companies VCT2 plc ("the Company")

 

Interim Management Statement

For the quarter ended 31 March 2013

 

British Smaller Companies VCT2 plc presents its interim management statement for the period from 1 January 2013 to 31 March 2013, including relevant financial information from the end of that period to 30 April 2013, being the date of this announcement. This constitutes the Company's first interim management statement for the financial year ending 31 December 2013, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.

 

The total return at 31 March 2013, calculated by reference to the net asset value per ordinary share and the cumulative dividends paid per ordinary share, was 101.3 pence per ordinary share. In the quarter there has been an increase of 1.3 pence per ordinary share in the total return to shareholders (equivalent to 1.3%) mainly as a result of the increase in valuation seen in the Company's unquoted investment portfolio.

 

The unaudited net asset value per ordinary share as at 31 March 2013 was 66.8 pence representing an increase of 1.3 pence per ordinary share (equivalent to 2%) from 65.5 pence per ordinary share as at 31 December 2012. These figures are before any provision for the proposed final dividend of 2.5 pence per ordinary share in respect of the year to 31 December 2012. This level of dividend is an increase of 0.5 pence per ordinary share on the 2011 final dividend. If the final dividend is approved at the Company's Annual General Meeting on 20 May 2013 it will be paid on 5 June 2013 to shareholders on the register as at 3 May 2013.

 

The number of ordinary shares in issue at 31 March 2013 was 41,457,844 (31 December 2012: 41,457,844). In addition, at 31 March 2013, the Company held 1,252,761 ordinary shares in treasury (31 December 2012: 1,252,761).

 

 

Net assets at 31 March 2013 comprised the following:

£000

% of net assets

Unquoted investments at fair value

9,930

35.9

Quoted investments at bid price

1,669

6.0

Gilt investments

915

3.3

Total investments

12,514

45.2

Cash and cash equivalents

7,702

27.8

Cash on fixed term deposit

7,048

25.5

Other net current assets

414

1.5

Net assets

27,678

54.8

 

The above cash balance includes £2.1 million relating to the allotment of shares on 31 December 2012.

 

The ten largest investments by valuation at 31 March 2013 were as follows:

 

£000

% of net assets

Displayplan Holdings Limited

1,638

5.9

Seven Technologies Holdings Limited

1,167

4.2

Digital Healthcare Limited

1,059

3.8

Immunobiology Limited

987

3.6

Deep-Secure Limited

983

3.6

Insider Technologies (Holdings) Limited

806

2.9

Bluebell Telecoms Group Limited

608

2.2

PowerOasis Limited

567

2.0

Waterfall Services Limited

434

1.6

Harvey Jones Holdings Limited

419

1.5

8,668

31.3

Other investments

2,931

10.6

Gilt investments

915

3.3

Total investments

12,514

45.2

 

 

During the three months ended 31 March 2013 the Company made one follow-on investment of £0.07 million into existing portfolio company PowerOasis Limited, a provider of energy management solutions to telecoms infrastructure operators. This investment was part of a significant $5 million investment round led by a strategic trade investor.

 

In the 3 months to 31 March 2013 aggregate cash proceeds of £0.41 million were received relating to the sale of the Company's holdings in Tikit Group plc and May Gurney Integrated Services plc generating a profit on cost of £0.07 million in the quarter.

 

Following the end of the quarter, on 5 April 2013 the Company issued 4,428,298 new ordinary shares as part of the linked offer with British Smaller Companies VCT plc, raising £2,907,109 million net of costs. Unquoted portfolio business Cambridge Cognition Limited has also achieved a successful listing on the AiM market raising £5m to fund sales growth of its cognitive testing software.

 

On 18 April 2013 the Company purchased 279,961 ordinary shares at a price of 59.20 pence per ordinary share. These shares are held in treasury.

 

Performance

 

The portfolio value increased by 1.4 pence per ordinary share in the quarter although growth in net asset value per ordinary share was slightly lower at 1.3 pence including other costs. The majority of this increase is attributed to the unquoted investments with several investee companies reporting profit growth in the period.

 

Outlook

 

The Board believes that the current economic climate will continue to create investment opportunities in the short to medium term in well run and managed UK businesses that need capital to expand but are facing a shortage of finance. History has shown us that cautious investments made in the low point of the economic cycle have resulted in the highest portfolio returns. Additionally the investment limit applying to venture capital trusts has been increased to £5 million per investment in any one year. A number of investment opportunities are currently being assessed for investment and the Company is well placed to take advantage of these following the recent new share issue.

 

 

30 April 2013

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Matt Thomas N+1 Singer Tel: 0207 496 3000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSURAAROSASOAR
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.